ClinicalTrials.gg
RecruitingNCT06491823Updated Feb 19, 2026

Speech Motor Learning and Retention (Aim 2)

An interventional study of Adaptation and Adaptation baseline in Speech, sponsored by Yale University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-19.

Sponsored by Yale University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Oct 2024; still recruiting 2 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The overall goal of this research is to test a new model of speech motor learning, whose central hypothesis is that learning and retention are associated with plasticity not only in motor areas of the brain but in auditory and somatosensory regions as well. The strategy for the proposed research is to identify individual brain areas that contribute causally to retention by disrupting their activity with transcranial magnetic stimulation (TMS). Investigators will also use functional magnetic resonance imaging (fMRI) which will enable identification of circuit-level activity which predicts either learning or retention of new movements, and hence test the specific contributions of candidate sensory and motor zones. In other studies, investigators will record sensory and motor evoked potentials over the course of learning to determine the temporal order in which individual sensory and cortical motor regions contribute. The goal here is to identify brain areas in which learning-related plasticity occurs first and which among these areas predict subsequent learning.

Read the detailed description

The focus of this registration is Aim 2. Specific Aim 2 assesses the temporal order in which plasticity occurs in cortical motor and sensory brain areas during speech motor learning. Plasticity is assessed using measures of cortical excitability. Specifically, auditory, somatosensory and motor evoked potentials are elicited using single pulse TMS (motor), pure tone bursts (auditory), and mentalis nerve stimulation (somatosensory). Tests of cortical excitability are interleaved with trials involving speech motor adaptation. Cortical excitability is also measured using these same measures 24 hours after learning to assess retention.

The Speech Motor Learning and Retention Master Protocol is NCT06467292.

02

Conditions studied

  • Speech

Browse trials for

Keywords

  • Speech Motor Learning
  • Retention
03

In context

Speech

205 studies on the registry are indexed under Speech; 80 are open to participants now.

This study's planned enrollment of 120 is above the median of 52 across 141 interventional studies indexed under Speech.

Browse Speech studies →

Lead sponsor

Yale University is the lead sponsor of 1,770 studies on the registry; 294 are open to participants now.

Of its 221 completed or terminated interventional studies of FDA-regulated products, 129 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Fluent English speakers
  • Right-handed
  • Normal hearing
  • No speech disorder or reading disability

Exclusion criteria

Exclusion Criteria:

  • Cardiac pacemaker
  • Aneurysm clip
  • Heart or Vascular clip
  • Prosthetic valve
  • Metal implants
  • Metal in brain, skull, or spinal cord
  • Implanted neurostimulator
  • Medication infusion device
  • Cochlear implant or tinnitus (ringing in ears)
  • Personal and/or family history of epilepsy or other neurological disorders or history of head concussion
  • Psychoactive medications
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    MEPs (M1) / altered auditory feedback / MEPs + retention tests at 24h

    Evoked potentials will be recorded from brain area M1 (motor cortex) in combination with a speech motor learning procedure known as adaptation to altered auditory feedback. Retention of learning will be tested 24h later along with additional evoked potential recordings.

    Behavioral: Adaptation · Device: Motor evoked potentials

  • Experimental
    AEPs (A1) / altered auditory feedback / AEPs + retention tests at 24h

    Evoked potentials will be recorded from brain area A1 (auditory cortex) in combination with a speech motor learning procedure known as adaptation to altered auditory feedback. Retention of learning will be tested 24h later along with additional evoked potential recordings.

    Behavioral: Adaptation · Device: Auditory evoked potentials

  • Experimental
    SEPs (S1) / altered auditory feedback / SEPs + retention tests at 24h

    Evoked potentials will be recorded from brain area S1 (somatosensory cortex) in combination with a speech motor learning procedure known as adaptation to altered auditory feedback. Retention of learning will be tested 24h later along with additional evoked potential recordings.

    Behavioral: Adaptation · Device: Somatosensory evoked potentials

  • Experimental
    MEPs (M1) / unaltered auditory feedback / MEPs + retention tests at 24h

    Evoked potentials will be recorded from brain area M1 (motor cortex) in combination with unaltered auditory feedback. Retention of learning will be tested 24h later along with additional evoked potential recordings.

    Behavioral: Adaptation baseline · Device: Motor evoked potentials

  • Experimental
    AEPs (A1) / unaltered auditory feedback / AEPs + retention tests at 24h

    Evoked potentials will be recorded from brain area A1 (auditory cortex) in combination with unaltered auditory feedback. Retention of learning will be tested 24h later along with additional evoked potential recordings.

    Behavioral: Adaptation baseline · Device: Auditory evoked potentials

  • Experimental
    SEPs (S1) / unaltered auditory feedback / SEPs + retention tests at 24h

    Evoked potentials will be recorded from brain area S1 (somatosensory cortex) in combination with unaltered auditory feedback. Retention of learning will be tested 24h later along with additional evoked potential recordings.

    Behavioral: Adaptation baseline · Device: Somatosensory evoked potentials

Interventions

  • BehavioralAdaptation

    Auditory adaptation in speech

  • BehavioralAdaptation baseline

    Auditory baseline in speech

  • DeviceMotor evoked potentials

    motor evoked potentials will be obtained in each recording block

  • DeviceAuditory evoked potentials

    auditory evoked potentials will be obtained in each recording block

  • DeviceSomatosensory evoked potentials

    Somatosensry evoked potentials will be obtained in each recording block

06

What researchers measure

Primary outcomes

  1. Speech motor learning

    Audapter software will be used to alter the first and second formant frequencies of the spoken words and this is played back to subjects through headphones. Subjects will be tested both with unaltered feedback and with abruptly introduced frequency shifts.The change in the first (F1) and second format frequency (F2) values will be assessed using Praat.

    Time frame: Performance as measured at the end of learning (30 minute session)

  2. Retention of learning

    The retention of adaptation to altered auditory feedback (and relearning) will be quantified in terms of F1 and F2 frequency shifts (relative to pre-training baseline). Larger values indicate more complete relearning or retention.

    Time frame: 24 hours after learning (re-test lasts 30 minutes)

  3. Motor evoked potentials (MEPs)

    Motor evoked potentials (MEPs) using single-pulse TMS will be recorded using surface electromyography (EMG) to measure MEP peak-to-peak response

    Time frame: Performance as measured at the end of learning (30 minute session)

  4. Somatosensory evoked potentials (SEPs)

    Electrical stimulation will be used to elicit somatosensory evoked potentials (SEPs). SEPs will be recorded using electroencephalogram (EEG) to measure the SEP response in the interval 20 to 25 ms following stimulation (N20-P25 response).

    Time frame: Performance as measured at the end of learning (30 minute session)

  5. Auditory evoked potentials (AEPs)

    Acoustical stimulation will be used to elicit auditory evoked potentials (AEPs). AEPs will be recorded using electroencephalogram (EEG) to measure the AEP response in the interval between the first positive peak and first negative peak following stimulation (P1-N1 response).

    Time frame: Performance as measured at the end of learning (30 minute session)

07

Study locations

1 of 1 sites recruiting
  • Yale Child Study Center
    New Haven, Connecticut 06520, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06491823
Lead sponsor
Yale University
Responsible party
Sponsor
First posted
Jul 9, 2024
Start date
Oct 1, 2024
Primary completion
Nov 30, 2028 (estimated)
Completion
May 31, 2029 (estimated)
Last update
Feb 19, 2026

Study contacts

David Ostry
Contact
david.ostry@yale.edu
2038656163
David Ostry
principal investigator · Yale University

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion